Bliss GVS Pharma
BLISSGVS.NS
#6718
Rank
NZ$1.36 B
Marketcap
NZ$12.88
Share price
0.70%
Change (1 day)
299.39%
Change (1 year)

Earnings for Bliss GVS Pharma (BLISSGVS.NS)

Earnings in 2026 (TTM): NZ$45.5 Million

According to Bliss GVS Pharma's latest financial reports the company's current earnings are NZ$0.11 Billion. In 2025 the company made an earning of NZ$37.35 Million, an increase over its 2024 earnings that were of NZ$22.62 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bliss GVS Pharma from 2016 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$45.5 M21.82%
2025 NZ$37.35 M65.08%
2024 NZ$22.62 M-15.94%
2023 NZ$26.91 M-14.25%
2022 NZ$31.38 M162.91%
2021 NZ$11.93 M-50.09%
2020 NZ$23.91 M-38.83%
2019 NZ$39.1 M10.15%
2018 NZ$35.49 M-45.49%
2017 NZ$65.12 M35.64%
2016 NZ$48 M